Table 3.
Multivariate linear regression with volumes of cerebral structures as outcome variables.
| Adjusted for age and sex |
Multivariable analysis |
|||||||
|---|---|---|---|---|---|---|---|---|
| β | 95% CI | p | β | 95% CI | p | |||
| Hippocampus | ||||||||
| Age | −0.003 | −0.004 to–0.002 | <0.000001 | |||||
| Sexa | −0.021 | −0.035 to–0.007 | 0.003 | |||||
| Probable parental LOADb | −0.018 | −0.034 to–0.003 | 0.019 | −0.015 | −0.031 to 0.001 | 0.058 | ||
| ApoE ɛ4c | −0.021 | −0.033 to–0.008 | 0.001 | −0.016 | −0.029 to–0.003 | 0.015 | ||
| Smoking (ever) | 0.00004 | −0.150 to 0.150 | 1.00 | 0.002 | −0.012 to 0.016 | 0.83 | ||
| BMI | 0.002 | 0.000 to 0.003 | 0.036 | 0.001 | −0.001 to 0.002 | 0.27 | ||
| Hypertension (ever) | −0.005 | −0.018 to 0.008 | 0.46 | −0.003 | −0.017 to 0.011 | 0.69 | ||
| Systolic BP (mm Hg) | 0.0001 | 0.0002 to 0.0004 | 0.42 | 0.0002 | −0.0001 to 0.001 | 0.23 | ||
| Total cholesterol (mmol) | 0.006 | 0.000 to 0.011 | 0.049 | 0.007 | 0.001 to 0.013 | 0.015 | ||
| Diabetes (ever) | −0.0001 | −0.026 to 0.025 | 0.99 | −0.0003 | −0.033 to 0.033 | 0.99 | ||
| HbA1c (%) | 0.005 | −0.005 to 0.015 | 0.35 | 0.005 | −0.007 to 0.018 | 0.38 | ||
| eGFR (ml/min/1.73 m2) | −0.0004 | −0.001 to 0.0002 | 0.17 | −0.001 | −0.001 to–0.00002 | 0.045 | ||
| Cobalamin (pmol) | 0.00003 | −0.00001 to 0.00007 | 0.15 | 0.000006 | −0.00004 to 0.00005 | 0.78 | ||
| Folic acid (nmol) | 0.0004 | −0.0005 to 0.001 | 0.41 | −0.0004 | −0.001 to 0.001 | 0.39 | ||
| tHcy (μmol) | −0.002 | −0.003 to–0.004 | 0.010 | −0.002 | −0.004 to–0.001 | 0.004 | ||
| Amygdala* | ||||||||
| BMI | 0.001 | 0.0004 to 0.002 | 0.003 | 0.001 | 0.0003 to 0.002 | 0.008 | ||
| Total cholesterol (mmol) | 0.002 | −0.001 to 0.005 | 0.22 | 0.004 | 0.0004 to 0.007 | 0.029 | ||
| tHcy (μmol) | −0.001 | −0.001 to 0.0001 | 0.10 | −0.001 | −0.002 to–0.0001 | 0.028 | ||
| Cerebral cortex* | ||||||||
| eGFR (ml/min/1.73 m2) | −0.015 | −0.036 to 0.006 | 0.16 | −0.028 | −0.050 to–0.005 | 0.016 | ||
| Folic acid (nmol) | −0.021 | −0.052 to 0.010 | 0.19 | −0.047 | −0.084 to–0.010 | 0.013 | ||
| tHcy (µmol) | −0.022 | −0.067 to 0.023 | 0.34 | −0.080 | −0.137 to–0.024 | 0.006 | ||
| Cerebrum* | ||||||||
| Total cholesterol (mmol) | 0.004 | 0.00009 to 0.007 | 0.045 | 0.004 | 0.001 to 0.008 | 0.023 | ||
| eGFR (ml/min/1.73 m2) | −0.0001 | −0.0005 to 0.0002 | 0.46 | −0.0004 | −0.001 to–0.00004 | 0.030 | ||
| Folic acid (nmol) | −0.0003 | −0.001 to–0.0002 | 0.21 | −0.001 | −0.001 to–0.0002 | 0.013 | ||
| tHcy (μmol) | −0.0005 | −0.001 to 0.0003 | 0.19 | −0.001 | −0.002 to–0.0004 | 0.006 | ||
| LnLateral ventricle* | ||||||||
| Total cholesterol (mmol) | −0.024 | −0.044 to–0.003 | 0.25 | −0.030 | −0.052 to–0.008 | 0.007 | ||
| Diabetes (ever) | 0.093 | 0.001 to 0.184 | 0.047 | 0.135 | 0.012 to 0.257 | 0.031 | ||
| tHcy (μmol) | 0.005 | 0.0001 to 0.009 | 0.044 | 0.005 | −0.0002 to 0.011 | 0.061 | ||
Adjusted for age and sex and in multivariable analysis. With cerebral white matter and cerebral WMH as outcome variables, there were no significant/borderline significant associations. All cerebral volumes are bilateral. BMI = Body mass index; BP = mean of the last two of three resting blood pressures; Ln = natural logarithm; WMH = white matter hyperintensities. Bold font = Significant/borderline significant.
Only variables which were significant/borderline significant in multivariate analysis are displayed.
Female = 0 and male = 1.
No parental LOAD = 0 and probable parental LOAD = 1.
No ApoE ɛ4 alleles = 0 and presence of one or both ApoE ɛ4 alleles = 1.